Showing results (351-360 of 384) with videos related to

Sort By:
Pageof 39
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 22, 2008
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistryHadi Yaziji, Clive R Taylor, Neal S Goldstein, et al.
Molecular and Cellular Biology|August 12, 2024
MANCR lncRNA Modulates Cell-Cycle Progression and Metastasis by Cis-Regulation of Nuclear Rho-GEFDeepak K Singh, Zhengmin Cong, You Jin Song, et al.
Breast Cancer Research : BCR|September 1, 2010
Breast cancer prognostic classification in the molecular era: the role of histological gradeEmad A Rakha, Jorge S Reis-Filho, Frederick Baehner, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2024
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
The Lancet. Healthy Longevity|January 20, 2022
Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older womenNeil Carleton, Azadeh Nasrazadani, Kristine Gade, et al.
Clinical Breast Cancer|May 16, 2025
Biologically Informed Decision-Making for PMRT in pT3N0M0 Luminal Breast Cancers (Protocol MF22-02): International Multicenter Real-World DataAtilla Soran, Melis Bahadir Gultekin, Bhanu Prasad Venkatesulu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2010
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologistsSunil Badve, David J Dabbs, Stuart J Schnitt, et al.
Communications Medicine|May 23, 2022
Determining breast cancer biomarker status and associated morphological features using deep learningPaul Gamble, Ronnachai Jaroensri, Hongwu Wang, et al.
Pageof 39